Vedolizumab, ustekinumab best anti-TNF for infection risk in older adult IBD - Healio

SAN DIEGO — Vedolizumab and ustekinumab associated with a lower risk for infection-related hospitalizations compared with anti-tumor necrosis factor agents in patients who initiated inflammatory bowel disease therapy at an older age. “It used to b…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio SAN DIEGO — Vedolizumab and ustekinumab … [+2393 chars]

full article...